OR2T6 and breast cancer: OR2T6, which is overexpressed in breast cancer cell lines (MCF-7 and MDA-MB-231), was associated with the progression of breast cancer cells via the epithelial–mesenchymal transition (EMT)-mediated mitogen-activated protein kinase (MAPK) pathway and suppression of apoptosis.